Anti-TEX261 monoclonal antibody
Pre-made anti-TEX261 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to TEX261/TEX261 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP1906-Ab-1/ GM-Tg-hg-IP1906-Ab-2 | Anti-Human TEX261 monoclonal antibody | Human |
GM-Tg-rg-IP1906-Ab-1/ GM-Tg-rg-IP1906-Ab-2 | Anti-Rat TEX261 monoclonal antibody | Rat |
GM-Tg-mg-IP1906-Ab-1/ GM-Tg-mg-IP1906-Ab-2 | Anti-Mouse TEX261 monoclonal antibody | Mouse |
GM-Tg-cynog-IP1906-Ab-1/ GM-Tg-cynog-IP1906-Ab-2 | Anti-Cynomolgus/ Rhesus macaque TEX261 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP1906-Ab-1/ GM-Tg-felg-IP1906-Ab-2 | Anti-Feline TEX261 monoclonal antibody | Feline |
GM-Tg-cang-IP1906-Ab-1/ GM-Tg-cang-IP1906-Ab-2 | Anti-Canine TEX261 monoclonal antibody | Canine |
GM-Tg-bovg-IP1906-Ab-1/ GM-Tg-bovg-IP1906-Ab-2 | Anti-Bovine TEX261 monoclonal antibody | Bovine |
GM-Tg-equg-IP1906-Ab-1/ GM-Tg-equg-IP1906-Ab-2 | Anti-Equine TEX261 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP1906-Ab-1/ GM-Tg-hg-IP1906-Ab-2; GM-Tg-rg-IP1906-Ab-1/ GM-Tg-rg-IP1906-Ab-2; GM-Tg-mg-IP1906-Ab-1/ GM-Tg-mg-IP1906-Ab-2; GM-Tg-cynog-IP1906-Ab-1/ GM-Tg-cynog-IP1906-Ab-2; GM-Tg-felg-IP1906-Ab-1/ GM-Tg-felg-IP1906-Ab-2; GM-Tg-cang-IP1906-Ab-1/ GM-Tg-cang-IP1906-Ab-2; GM-Tg-bovg-IP1906-Ab-1/ GM-Tg-bovg-IP1906-Ab-2; GM-Tg-equg-IP1906-Ab-1/ GM-Tg-equg-IP1906-Ab-2 |
Products Name | Anti-TEX261 monoclonal antibody |
Format | mab |
Target Name | TEX261 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-TEX261 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP1906-Ag-1 | Recombinant multi-species TX261/ TEX261/ TEG-261 protein |
ORF Viral Vector | pGMAAV000336 | Norway rat Tex261 AAV plasmid |
ORF Viral Vector | vGMAAV000336 | Norway rat Tex261 AAV particle |
Target information
Target ID | GM-IP1906 |
Target Name | TEX261 |
Gene ID | 113419,21766,297392,703863,481425,101098533,514869,100060120 |
Gene Symbol and Synonyms | 3110001O07Rik,TEG-261,TEX261 |
Uniprot Accession | Q6UWH6,Q5BJW3,Q58DA4 |
Uniprot Entry Name | TX261_HUMAN,TX261_RAT,TX261_BOVIN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000144043 |
Target Classification | N/A |
The target: TEX261, gene name: TEX261, also named as TEG-261. Predicted to enable COPII receptor activity. Predicted to be involved in endoplasmic reticulum to Golgi vesicle-mediated transport. Predicted to act upstream of or within positive regulation of apoptotic process. Predicted to be located in cytoplasm. Predicted to be integral component of membrane. Predicted to be active in COPII-coated ER to Golgi transport vesicle. Predicted to be integral component of Golgi membrane and integral component of endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.